Chandrakala Shanmukhaiah

Safety and efficacy of long‐term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single‐arm study (STASEY)

Víctor Jiménez‐Yuste, Flora Peyvandi, Robert Klamroth et al. · Research and Practice in Thrombosis and Haemostasis · 2022 · 48 citations · Full text

Thrombosis, Hematology, Factor Viii Inhibitors +6

Genetic variations of hOCT1 gene and CYP3A4/A5 genes and their association with imatinib response in Chronic Myeloid Leukemia

Shantashri Vaidya, Kanjaksha Ghosh, Chandrakala Shanmukhaiah et al. · European Journal of Pharmacology · 2015 · 30 citations

Hematological Malignancy, Chromatin, Chronic Myeloid Leukemia +8

Evolution of BCR/ABL Gene Mutation in CML Is Time Dependent and Dependent on the Pressure Exerted by Tyrosine Kinase Inhibitor

Shantashri Vaidya, Babu Rao Vundinti, Chandrakala Shanmukhaiah et al. · PLoS ONE · 2015 · 28 citations · Full text

Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/<i>β</i> catenin pathways in Lin−/CD38−/CD34+ cells in acute myeloid leukemia

Swati Garg, Chandrakala Shanmukhaiah, Supreet P Marathe et al. · European Journal Of Haematology · 2015 · 21 citations

Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes

Pallavi Mehta, Dipti Upadhye, Pratibha Sawant et al. · Annals of Hematology · 2015 · 21 citations

Immunohematology, Transfusion Requirements, Laboratory Hematology +10